Literature DB >> 12854167

High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.

Ulf Gustafsson1, Staffan Sahlin, Curt Einarsson.   

Abstract

AIM: To study whether patients with excess deoxycholic acid (DCA) differ from those with normal percentage of DCA with respect to biliary lipid composition and cholesterol saturation of gallbladder bile.
METHODS: Bile was collected during operation through puncturing into the gallbladder from 122 cholesterol gallstone patients and 46 gallstone-free subjects undergoing cholecystectomy. Clinical data, biliary lipids, bile acid composition, presence of crystals and nucleation time were analyzed.
RESULTS: A subgroup of gallstone patients displayed a higher proportion of DCA in bile than gallstone free subjects. By choosing a cut-off level of the 90th percentile, a group of 13 gallstone patients with high DCA levels (mean 50 percent of total bile acids) and a large group of 109 patients with normal DCA levels (mean 21 percent of total bile acids) were obtained. The mean age of the patients with high DCA levels was higher than that of the group with normal levels (mean age: 62 years vs 45 years) and so was the mean BMI (28.3 vs. 24.7). Plasma levels of cholesterol and triglycerides were slightly higher in the DCA excess groups compared with those in the normal DCA group. There was no difference in biliary lipid composition, cholesterol saturation, nucleation time or occurrence of cholesterol crystals in bile between patients with high and normal levels of DCA.
CONCLUSION: Gallstone patients with excess DCA were of older age and had higher BMI than patients with normal DCA. The two groups of patients did not differ with respect to biliary lipid composition, cholesterol saturation, nucleation time or occurrence of cholesterol crystals. It is concluded that DCA in bile does not seem to contribute to gallstone formation in cholesterol gallstone patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854167      PMCID: PMC4615508          DOI: 10.3748/wjg.v9.i7.1576

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Enzymatic determination of cholesterol in bile.

Authors:  A Roda; D Festi; C Sama; G Mazzella; R Alini; E Roda; L Barbara
Journal:  Clin Chim Acta       Date:  1975-11-03       Impact factor: 3.786

2.  Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase.

Authors:  O Fausa; B A Skålhegg
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

4.  Deoxycholic acid is not related to lithogenic factors in gallbladder bile.

Authors:  D Jüngst; I Müller; G A Kullak-Ublick; G Meyer; E Frimberger; S Fischer
Journal:  J Lab Clin Med       Date:  1999-04

5.  Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.

Authors:  F Azzaroli; G Mazzella; C Mazzeo; P Simoni; D Festi; A Colecchia; M Montagnani; C Martino; N Villanova; A Roda; E Roda
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones.

Authors:  F Berr; G A Kullak-Ublick; G Paumgartner; W Münzing; P B Hylemon
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

7.  Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.

Authors:  H Noshiro; K Chijiiwa; I Makino; K Nakano; I Hirota
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

8.  Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallbladder bile.

Authors:  K J van Erpecum; P Portincasa; M F Stolk; B J van de Heijning; E S van der Zaag; A M van den Broek; G P van Berge Henegouwen; W Renooij
Journal:  Eur J Clin Invest       Date:  1994-11       Impact factor: 4.686

9.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

10.  Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

View more
  4 in total

1.  Discovering novel bile protection systems in Bifidobacterium breve UCC2003 through functional genomics.

Authors:  Lorena Ruiz; Aldert Zomer; Mary O'Connell-Motherway; Douwe van Sinderen; Abelardo Margolles
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

2.  Effects of cholesterol on proliferation and functional protein expression in rabbit bile duct fibroblasts.

Authors:  Bao-Ying Chen; Jing-Guo Wei; Yao-Cheng Wang; Jun Yu; Ji-Xian Qian; Yan-Ming Chen; Jing Xu
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

3.  Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany.

Authors:  Clemens Schafmayer; Jürgen Hartleb; Jürgen Tepel; Stefan Albers; Sandra Freitag; Henry Völzke; Stephan Buch; Markus Seeger; Birgit Timm; Bernd Kremer; Ulrich R Fölsch; Fred Fändrich; Michael Krawczak; Stefan Schreiber; Jochen Hampe
Journal:  BMC Gastroenterol       Date:  2006-11-22       Impact factor: 3.067

4.  Campylobacter jejuni type VI secretion system: roles in adaptation to deoxycholic acid, host cell adherence, invasion, and in vivo colonization.

Authors:  Kvin Lertpiriyapong; Eric R Gamazon; Yan Feng; Danny S Park; Jassia Pang; Georgina Botka; Michelle E Graffam; Zhongming Ge; James G Fox
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.